← FDA DRUG APPROVALS

FDA ANDA · ANDA040489

METHOCARBAMOL

Sponsor: OXFORD PHARMS

APPLICATION
ANDA040489
TYPE
ANDA
ORIGINAL APPROVAL
2003-01-29
LATEST ACTION
2020-07-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHOCARBAMOLPrescription
METHOCARBAMOL 750MG · TABLET · ORAL
METHOCARBAMOLPrescription
METHOCARBAMOL 500MG · TABLET · ORAL

Approval history

2020-07-02Labeling · Supplement 15 · standardAP
2005-05-05Labeling · Supplement 1AP
2003-01-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →